{"id":112841,"name":"AMERICAN ASSOCIATION OF BIOANALYSTS","slug":"american-association-of-bioanalysts","state":"MO","description":"professional association committed to the pursuit of excellence in clinical lab services.","totalSpending":2460000,"filings":34,"yearlySpending":[{"year":2018,"income":280000},{"year":2019,"income":280000},{"year":2020,"income":350000},{"year":2021,"income":210000},{"year":2022,"income":500000},{"year":2023,"income":280000},{"year":2024,"income":280000},{"year":2025,"income":280000}],"firms":["CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C."],"lobbyists":["ERIN WILL MORTON","CELIA HAGAN","BECCA BRANUM","MEGHAN RILEY","ERIKA MILLER","MATTHEW DENNIS","ALYSSA AFRAM","STEFANIE RINEHART","KELSI PUTNAM"],"issues":["MMM","HCR",null],"sampleDescriptions":["Protecting Access to Medicare Beneficiaries Act of 2014, H.R. 4302\nP.L. 113-93\nReimbursement for clinical laboratories\nClinical Laboratory Fee Schedule (CLFS)","Protecting Access to Medicare Beneficiaries Act of 2014, HR 4302\nP.L. 113-93\nReimbursement for clinical laboratories\nClinical Laboratory Fee Schedule (CLFS)\nEliminating Kickbacks in Recovery Act (EKRA) of 2018","Protecting Access to Medicare Beneficiaries Act of 2014, HR 4302\nP.L. 113-93\nReimbursement for clinical laboratories\nClinical Laboratory Fee Schedule (CLFS)\nEliminating Kickbacks in Recovery Act (EKRA) of 2018\nLAB Act (HR 3584)\nSurprise Billing","COVID-19\nPL 116-136: CARES Act\nPL 116-127: Family First Coronavirus Response Act \nPL 116-127: Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020","COVID-19\nPL 116-136: CARES Act\nPL 116-127: Family First Coronavirus Response Act \nPL 116-123: Coronavirus Preparedness and Response Supplemental\nPL 116-139: PPP and Health Care Enhancement Act","Medicare Clinical Laboratory Fee \nSchedule Issues\nP.L. 113-93, Protecting Access to Medicare Beneficiaries Act of 2014\nP.L. 115-271, SUPPORT for Patients and Communities Act (EKRA)","COVID-19 supplies and other issues","Medicare Clinical Laboratory Fee","Medicare Clinical Laboratory Fee Schedule","COVID-19 testing reimbursement through HRSA","FDA oversight of laoratory developed tests","Medicare Clinical Laboratory Fee Schedule, HR 2377/S 1000","Oversight of Laboratory Developed Tests","Medicare Clinical Laboratory Fee Schedule; PAMA reform","Medicare Clinical Laboratory Fee Schedule, The RESULTS Act (HR 5269/S 2761)"],"years":[2018,2019,2020,2021,2022,2023,2024,2025]}